SCHEMBL12550248

SCHEMBL12550248

CCn1ccc2scc(Br)c21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12549886 0.81 CYP2A6 (0.32) —
SCHEMBL16860626 0.66 — —
SCHEMBL6030394 0.65 CYP19A1 (0.45) —
SCHEMBL14985269 0.64 KDM1A (0.34) —
SCHEMBL24016979 0.63 — —
SCHEMBL16475178 0.62 F2RL1 (0.33) —
SCHEMBL20101431 0.61 HTR2A (0.43) —
SCHEMBL27267915 0.61 DDR1 (0.31) —
SCHEMBL25282200 0.61 TUBB4A (0.40) —
SCHEMBL17963571 0.60 CCNT1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8404736-B2 Heterocyclic amide derivatives as EP4 receptor antagonists BETA PHARMA CANADA INC. (CA) 2013-03-26 — — US disclosed
US-20110136887-A1 Heterocyclic Amide Derivatives as EP4 Receptor Antagonists BETA PHARMA CANADA INC. (CA) 2011-06-09 — — US disclosed
Send feedback